Zevra Therapeutics

📍 Celebration, United States🗓 Founded 2006👥 57 employees💰 Last funded Aug 2023
We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners, and advocacy groups in all of our clinical and regulatory development strategies. With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients. Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients’ lives.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2006
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Zevra Therapeutics?
Zevra Therapeutics has 1 investors on record on gritt.io.
When did Zevra Therapeutics last raise funding?
The most recent investment in Zevra Therapeutics recorded on gritt.io was in August 2023.
When was Zevra Therapeutics founded?
Zevra Therapeutics was founded in 2006.
What industry is Zevra Therapeutics in?
Zevra Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Zevra Therapeutics based?
Zevra Therapeutics is headquartered in Celebration, United States.